Gösterge TablosuPortföylerİzleme ListesiToplulukKeşfedinScreener
NOT FOR DISTRIBUTION

The Macerich Company

NYSE:MAC Stok Raporu

Piyasa değeri: US$6.7b

  • Şirkete Genel Bakış
    • Değerleme
    • Gelecekteki Büyüme
    • Geçmiş Performans
    • Finansal Sağlık
    • Temettü
  • Yönetim
  • Sahiplik
  • Diğer Bilgiler
  • Hisse Senedi Topluluğu

Macerich Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Macerich şirketinin kazançları yıllık ortalama -19.7% oranında azalırken, Retail REITs sektörünün kazançları yıllık 10.7% oranında artan oldu. Gelirler yıllık ortalama 5.3% oranında artan oldu.

Anahtar bilgiler

-19.70%

Kazanç büyüme oranı

-12.19%

EPS büyüme oranı

Retail REITs Sektör Büyümesi8.45%
Gelir büyüme oranı5.30%
Özkaynak getirisi-5.92%
Net Marj-16.58%
Son Kazanç Güncellemesi30 Jun 2026

Yakın geçmiş performans güncellemeleri

Recent updates

User avatar
Anlatı Güncellemesi • Sep 03

MAC: Forward Equity Raise And Leasing Progress Will Shape Medium Term Upside

For Macerich, the analyst price target update reflects a modest uplift in fair value from $21.23 to $22.85, as analysts factor in steady progress on the company's "Path Forward" plan, ongoing leasing momentum, and updated expectations for margins and future earnings multiples across recent research. Analyst Commentary Recent research on Macerich shows a mix of support for the "Path Forward" plan and fresh caution around how much upside is already reflected in the stock.
User avatar
Anlatı Güncellemesi • Aug 18

MAC: Path Forward Plan And Financing Moves Will Guide Balanced Repricing Potential

The analyst price target for Macerich has moved modestly higher, with the updated fair value estimate rising from $25.75 to $26.63 as analysts cite ongoing leasing progress, Path Forward Plan execution, and adjusted retail REIT models following recent earnings updates. Analyst Commentary Recent research updates on Macerich give you a mixed but generally constructive picture, with many firms lifting price targets while still watching execution risk around the Path Forward Plan, acquisitions, and valuation.
User avatar
Anlatı Güncellemesi • Aug 04

MAC: Equity Raises For Acquisitions May Cap Upside Despite Path Forward Progress

The updated Macerich price target of $21.23 reflects a modest increase from $19.85, aligning with analysts' higher $24 to $30 targets that are supported by progress on the Path Forward Plan, leasing momentum, adjusted FFO outlooks, and acquisition funding capacity. Analyst Commentary Recent research on Macerich shows a mix of optimism on the Path Forward Plan and leasing progress, alongside a clear pocket of caution around valuation, execution risk, and the durability of growth.
User avatar
Anlatı Güncellemesi • Jul 21

MAC: Path Forward Plan And Equity Raises Will Shape Balanced Repricing Potential

The analyst price target for Macerich has been raised from $24.31 to $25.75. This change reflects analysts' updated views on the company's "Path Forward Plan," leasing progress, acquisition funding from recent equity issuance, and revised FFO and valuation assumptions across several firms.
User avatar
Anlatı Güncellemesi • Jul 07

MAC: Equity Raises And Path Forward Execution Risks May Limit Upside

The analyst price target for Macerich has been lifted from $19.00 to about $19.85 as analysts factor in higher price objectives across the Street, citing progress on the "Path Forward Plan," improved leasing trends, updated FFO assumptions, and the potential impact of recent acquisition and funding activity. Analyst Commentary Recent Street research on Macerich shows a mix of optimism about the Path Forward Plan and leasing progress, alongside a pocket of caution around valuation, funding choices, and execution risk on longer term earnings targets.
Seeking Alpha • Jun 25

Macerich: Growth Story Hobbled By Debt

Summary Macerich is undergoing a major transformation, focusing on high-performing Class A malls and targeting Gen Z consumers for future growth. Despite impressive portfolio streamlining and leasing momentum, MAC remains constrained by high debt levels, elevated interest rates, and a below-average dividend yield. FFO per share is forecast to grow 11.3% in 2026 and 11.9% in 2027, with acquisitions and dispositions expected to balance out in 2026. Read the full article on Seeking Alpha
User avatar
Anlatı Güncellemesi • Jun 23

MAC: Path Forward Plan And Equity Raises May Support Measured Repricing Ahead

The analyst price target for Macerich has been raised from $23.13 to $24.31, with analysts citing progress on the "Path Forward" plan, improved earnings visibility, and updated targets across multiple firms as key drivers behind the change. Analyst Commentary Recent research on Macerich reflects a mix of optimism around the "Path Forward" plan and more cautious views on valuation and execution risk.
Analiz Makalesi • Jun 17

Macerich (MAC) Stock Could Be 25.5% Below Fair Value Despite Mixed Valuation Views

Macerich (MAC) stock has drawn investor attention after its recent performance, with the share price closing at $23.75 and total return figures highlighting a mix of shorter and longer term outcomes. See our latest analysis for Macerich. Recent trading has been choppy for Macerich, with the share price falling 5.34% over the last day even after a 30 day share price return of 9.95% and a year to date share price return of 28.24%. The 1 year total shareholder return of 55.45% and 3 year total...
User avatar
Anlatı Güncellemesi • Jun 07

MAC: Path Forward Plan And Deleveraging May Support Measured Repricing Ahead

Narrative Update The analyst price target for Macerich moves from $21.63 to $23.13 as analysts respond to the company's "Path Forward Plan," completed balance sheet deleveraging and portfolio simplification, modest guidance adjustments, and updated models following recent equity and earnings developments. Analyst Commentary Recent research on Macerich shows a mix of optimism and caution, with several firms updating models and price targets following the "Path Forward Plan," balance sheet changes, and an equity raise.
User avatar
Anlatı Güncellemesi • May 24

MAC: Equity Raise And Execution Risks Will Cap Future Upside Potential

Analysts have lifted the price target on Macerich to $19.00 from $15.58, citing refreshed models that reflect updated guidance, adjusted expectations for revenue decline and margins, and a range of recent price target increases across the Street. Analyst Commentary Recent Street research around Macerich points to a mix of optimism on execution and balance sheet progress, alongside ongoing debate about how fully the stock already reflects these improvements.
User avatar
Anlatı Güncellemesi • May 07

MAC: Path Forward Execution And Deleveraging May Support Balanced Repricing Ahead

Analysts have raised their average price target for Macerich by a few dollars to reflect recent target increases across several research firms, citing progress on the company's multi year "Path Forward Plan," asset sales, and balance sheet improvement as key supports for the updated view. Analyst Commentary Recent research updates present a mixed picture on Macerich, with several price target increases and a couple of rating changes that highlight both improving execution and ongoing debates about valuation and risk.
User avatar
Anlatı Güncellemesi • Apr 20

MAC: Path Forward Execution And Deleveraging Support Balanced Outlook As Models Update

The analyst price target for Macerich edges up from $21.38 to $21.63, as analysts factor in a modestly lower discount rate, steady revenue and margin assumptions, and recent Street research that highlights execution on the "Path Forward Plan," asset sales, deleveraging, and updated valuation models across several firms. Analyst Commentary Recent Street research on Macerich reflects a mix of optimism about the company’s execution and balance sheet progress, alongside ongoing caution on valuation and long term earnings power.
User avatar
Anlatı Güncellemesi • Apr 05

MAC: Path Forward Execution And Deleveraging Shape Balanced Outlook For Future Returns

Analysts nudged Macerich's fair value estimate to $21.38 from $21.19, citing updated models that reflect improved profit margin assumptions, a lower discount rate, and recent price target increases across the Street. Analyst Commentary Recent Street research on Macerich clusters around higher price targets and rating changes, with opinions split between optimism on execution and caution on valuation and sector fundamentals.
User avatar
Anlatı Güncellemesi • Mar 21

MAC: Path Forward Deleveraging And Asset Sales Will Drive Future Returns

The analyst price target for Macerich increases from $21.13 to $21.19 as analysts factor in updated models, recent price target revisions across the Street, and progress against the company's multi-year "Path Forward Plan." Analyst Commentary Recent research updates on Macerich reflect a mix of optimism around execution on the "Path Forward Plan" and caution on valuation and sector fundamentals. Price targets now span from the high teens to the mid twenties, with ratings ranging from Sell to Overweight.
User avatar
Anlatı Güncellemesi • Mar 07

MAC: Path Forward Execution And Deleveraging Will Shape Future Returns

The analyst price target for Macerich has moved higher to $21.13 from $20.13 as analysts point to updated expectations for the company’s Path Forward Plan, improving margin assumptions and revised P/E and discount rate inputs in recent research. Analyst Commentary Recent Street research on Macerich shows a mix of optimism around execution on the Path Forward Plan and caution around valuation and sector headwinds.
User avatar
Anlatı Güncellemesi • Feb 20

MAC: Peak Fundamentals And Occupancy Levels Will Limit Future Upside Potential

Analysts have lifted their price targets on Macerich, including one increase to $21. This change reflects updated views on discount rates, revenue trends, profit margins, and future P/E assumptions.
User avatar
Anlatı Güncellemesi • Feb 06

MAC: Sector Peak Concerns And Occupancy Expectations Will Shape Future Returns

Analysts have nudged their fair value estimate for Macerich up from about $19.86 to $20.13, citing a series of recent price target increases and updated sector views that reflect current expectations for occupancy and earnings quality. Analyst Commentary Bullish Takeaways Bullish analysts highlight the series of price target resets, from US$18 to US$19 and then above US$20, as support for a modestly higher fair value range for the shares.
User avatar
Anlatı Güncellemesi • Jan 22

MAC: Peak Occupancy Concerns Will Constrain Future Upside Potential

Narrative update on Macerich Analysts have nudged their fair value estimate for Macerich to about US$15.58 from US$15.00, reflecting recent price target increases across the Street as they refresh assumptions on growth, margins and long term P/E expectations. Analyst Commentary Recent Street research on Macerich has centered on refreshed price targets and sector views as firms revisit their models for U.S. real estate and REITs. While individual targets differ, the common thread is a reassessment of mall and shopping center fundamentals alongside updated assumptions for occupancy and earnings power.
User avatar
Anlatı Güncellemesi • Jan 08

MAC: Lower Discount Rate And P/E Assumptions Will Shape Future Returns

Narrative update on Macerich Analysts have lifted their price target on Macerich to about $19.86 from $19.53, reflecting updated views on discount rates, revenue trends, margins and long term P/E assumptions, in line with recent Street research that raised one target to $19. Analyst Commentary Recent commentary focuses on how updated discount rates, revenue trends, margin assumptions and long term P/E expectations feed into the fair value range for Macerich.
User avatar
Anlatı Güncellemesi • Sep 20

Experiential Retail Trends Will Revitalize Urban Leasing

Analysts modestly increased Macerich’s price target to $19.53, citing improved Q2 performance and a sector-wide REIT valuation reassessment, though concerns about the company’s risk profile persist. Analyst Commentary Bullish analysts increased price targets following updated financial models that reflect improved Q2 performance.
User avatar
Yeni Anlatı • Feb 10

Rising Interest Rates And Debt Reduction Plans May Erode Future Earnings

Reducing debt and strategic asset sales may cause revenue instability and transitional earnings impacts during restructuring efforts.
Seeking Alpha • Jan 07

Is Macerich Now A Buy?

Summary Macerich has rallied heavily over the last year as market enthusiasm builds over its Path Forward Plan. The REIT is currently trading for 13.5x times its annualized third-quarter FFO and offers a modest 3.31% dividend yield. The November equity offering should be accretive, but revenue is set to dip in future quarters on asset sales and givebacks. Read the full article on Seeking Alpha

Gelir ve Gider Dağılımı

Macerich nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NYSE:MAC Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 261,027-170340
31 Mar 261,024-184320
31 Dec 251,041-198320
30 Sep 251,100-390300
30 Jun 251,049-411290
31 Mar 251,012-118280
31 Dec 24899-195280
30 Sep 2478878280
30 Jun 24794-76280
31 Mar 24839-343300
31 Dec 23856-275290
30 Sep 23879-335290
30 Jun 23878-88300
31 Mar 23832-88270
31 Dec 22866-67270
30 Sep 22844-86280
30 Jun 2283836290
31 Mar 2286340290
31 Dec 2186813300
30 Sep 21823-160300
30 Jun 21786-289300
31 Mar 21715-302320
31 Dec 20759-231300
30 Sep 20831-14280
30 Jun 2090454260
31 Mar 2097495220
31 Dec 1997696230
30 Sep 1998781230
30 Jun 19997108230
31 Mar 191,016100230
31 Dec 181,02859240
30 Sep 181,04680250
30 Jun 181,04724250
31 Mar 181,04943280
31 Dec 171,044145280
30 Sep 171,060150260
30 Jun 171,066146280
31 Mar 171,080165280
31 Dec 161,085516280
30 Sep 161,131893300
30 Jun 161,204913300
31 Mar 161,261882300
31 Dec 151,322486300
30 Sep 151,3231,500350

Kaliteli Kazançlar: MAC şu anda kârlı değil.

Büyüyen Kar Marjı: MAC şu anda kârlı değil.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: MAC kârlı değildir ve zararlar son 5 yılda yılda 19.7% oranında artmıştır.

Büyüme Hızlandırma: MAC 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: MAC kârlı olmadığından, geçmiş yıl kazanç büyümesinin Retail REITs sektörüyle ( 29% ) karşılaştırılması zorlaşıyor.


Özkaynak Getirisi

Yüksek ROE: MAC hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -5.92% ) sahiptir.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/09/14 08:42
Gün Sonu Hisse Fiyatı2026/09/11 00:00
Kazançlar2026/06/30
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
  • SEC Form 10-K
  • SEC Form 10-Q
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
  • Analist Araştırma Raporları
  • Blue Matrix
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
  • ICE Piyasa Verileri
  • SEC Form S-1
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
  • SEC Form 4
  • SEC Form 13D
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
  • SEC Form 10-K
  • SEC Form DEF 14A
Önemli Gelişmeler10 yıl
  • Şirket duyuruları
  • SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

The Macerich Company 35 Bu analistlerden 5, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
null nullArgus Research Company
Ross SmotrichBarclays
Paul AdornatoBMO Capital Markets Equity Research

Her Yerde Daha İyi Yatırım Kararları Alın

İndirmek için tarayın
AppStore’u AçGoogle Play’i Aç
Chrome Web Mağazası
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Veri Kaynaklarını Görüntüle
Piyasalar
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Yatırım Fikirleri
  • Değeri Düşük Şirketler
  • Temettü Santralleri
  • İçeriden Satın Alma
  • Nükleer Enerji
  • Otonom Araçlar
  • Yapay Zeka
  • Kripto ve Blok Zinciri
  • Siber güvenlik
  • Daha fazla fikir
Hisse Toplulukları
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Araçlar ve özellikler
  • Portföy Takibi
  • Hisse Senedi Tarayıcı & Uyarılar
  • Anlatılar ve Adil Değerler
  • Temettü Hesaplayıcı
Haberler ve Keşifler
  • Son Hisse Senedi Haberleri
  • Küresel Pazar İçgörüleri
  • Foxhole
  • Yatırım Fikirleri
  • Topluluk Anlatıları
  • Yenilikler
Simply Wall St
  • Planlar & Fiyatlandırma
  • Reklam
  • Hakkımızda
  • Bize Ulaşın
  • Kariyer
  • Yardım Merkezi
  • Hisse Senedi Yatırımını Öğrenin
  • Ortaklık Programı
  • İşletme ve Kurumsal
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Şartlar ve Koşullar
  • Gizlilik Politikası
  • Yapay Zeka Koşulları
  • Finansal Hizmetler Rehberi